Florida Stem-Cell Supplier Draws Untitled Letter for False Claims
The FDA hit Florida stem-cell supplier RichSource Stem Cells with an untitled letter for unapproved claims relating to its RICHGEN stem cell product.
Source: Drug Industry Daily
The FDA hit Florida stem-cell supplier RichSource Stem Cells with an untitled letter for unapproved claims relating to its RICHGEN stem cell product.
Source: Drug Industry Daily